Anixa Biosciences Enters Material Definitive Agreement
Ticker: ANIX · Form: 8-K · Filed: May 8, 2024 · CIK: 715446
| Field | Detail |
|---|---|
| Company | Anixa Biosciences Inc (ANIX) |
| Form Type | 8-K |
| Filed Date | May 8, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-actions
TL;DR
Anixa Biosciences just signed a big deal, filing an 8-K on May 3rd.
AI Summary
Anixa Biosciences, Inc. announced on May 3, 2024, that it has entered into a material definitive agreement. The company, formerly known as ITUS Corp and COPYTELE INC, is incorporated in Delaware and headquartered in San Jose, California.
Why It Matters
This filing indicates a significant new development or contract for Anixa Biosciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not detailed in this initial filing.
Key Numbers
- 001-37492 — Commission File Number (SEC File Number for Anixa Biosciences)
- 11-2622630 — IRS Employer Identification No. (Tax identification number for Anixa Biosciences)
Key Players & Entities
- Anixa Biosciences, Inc. (company) — Registrant
- ITUS Corp (company) — Former company name
- COPYTELE INC (company) — Former company name
- May 3, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Jose, CA (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement?
The filing does not specify the details of the material definitive agreement, only that one has been entered into as of May 3, 2024.
What was Anixa Biosciences previously known as?
Anixa Biosciences, Inc. was formerly known as ITUS Corp and COPYTELE INC.
In which state is Anixa Biosciences incorporated?
Anixa Biosciences, Inc. is incorporated in Delaware.
Where are Anixa Biosciences' principal executive offices located?
Anixa Biosciences, Inc.'s principal executive offices are located at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118.
What is the SEC file number for Anixa Biosciences?
The SEC file number for Anixa Biosciences, Inc. is 001-37492.
Filing Stats: 1,138 words · 5 min read · ~4 pages · Grade level 13.2 · Accepted 2024-05-08 08:35:37
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ANIX The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-018170.txt ( ) — 246KB
- anix-20240503.xsd (EX-101.SCH) — 3KB
- anix-20240503_lab.xml (EX-101.LAB) — 33KB
- anix-20240503_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 99.1 Press Release, dated May 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 8, 2024 ANIXA BIOSCIENCES, INC. By: /s/ Michael J. Catelani Name: Michael J. Catelani Title: President, Chief Operating Officer and Chief Financial Officer